Go to deals
Healthcare

Lifco AB has acquired a majority stake in Rhein83 Srl

Lifco AB has acquired a majority stake in the Italian dental company Rhein83 Srl. Financial details have not been disclosed.

Lifco acquires and develops market-leading niche operations with the potential to deliver sustainable profit growth and strong cash flows. The group is listed on Nasdaq Stockholm and has three business areas: dental, demolition & tools and systems solutions. The company has a clear corporate philosophy which implies a long-term perspective, focus on profits and a highly decentralized organization. As of today, the investment group controls circa140 companies in 30 countries, generating revenues of over US$1 billion.

Established in 1983 and located in Bologna, Italy, Rhein83 has innovated the dental market with the introduction of elastic spherical attachments (previously were only metallic) for dental implants. The company's technology is highly recognized and appreciated worldwide.

Oaklins' team in Italy advised the buyer in this transaction.

Parties
“Italy has many leading companies active in niche markets. Rhein83 is one of them. We are very excited for having complete this first acquisition in Italy and we hope this will be the first of many other acquisitions, both in the dental and industrial sectors, where we are discovering outstanding companies with great performance.”

Ingvar Ljungqvist

Head of Acquisitions, Lifco AB

Talk to the deal team

Giuseppe Maria Bernardo Puccio

Principal
Milan, Italy
Oaklins Italy

Related deals

Leika Medical Equipments Ltd. has been acquired by Angus Capital
Private Equity | Healthcare

Leika Medical Equipments Ltd. has been acquired by Angus Capital

The shareholders of Leika Medical Equipments Ltd. have sold the company to Angus Capital.

Learn more
Phen’X Technologies has sold a majority stake to Ciclad
Private Equity | Healthcare | Industrial Machinery & Components

Phen’X Technologies has sold a majority stake to Ciclad

The shareholders of Phen’X Technologies have completed a primary majority LBO with private equity fund Ciclad.

Learn more
Medis Medical Imaging and GE HealthCare announce collaboration focused on non-invasive coronary assessments
Healthcare | TMT

Medis Medical Imaging and GE HealthCare announce collaboration focused on non-invasive coronary assessments

Medis Medical Imaging Systems B.V., a leading cardiac imaging software company, have completed a strategic investment to further develop its revolutionary non-invasive cardiovascular imaging solution. The company has announced its collaboration with GE HealthCare (Nasdaq: GEHC), a global leader in medical technology, pharmaceutical diagnostics and innovation in digital solutions, to contribute to the advancement of precision care in the diagnosis and treatment of coronary artery disease (CAD).

Learn more